Tag Archives: Cell

‘Executioner cell’ find may help to treat the causes of blindness

Researchers at Trinity College Dublin have identified a so-called “executioner cell” that may hold the key to eventually finding a treatment to slow retinal degeneration that causes blindness in millions of people each year. A multi-disciplinary team involving experts from TCD believe they have pinpointed a potential new therapeutic target for treating retinal degeneration. It… Read More »

Vaping flavored Juul pods damages lung cell DNA, raising cancer risks

Juul pod flavors like creme brulee, menthol and mint blamed for getting teens hooked on vaping raise risks for lung injuries and cancer by damaging DNA, study suggests Sweet e-cigarette liquid flavors have been blamed for getting teenagers addicted to vaping  But little is known about how the chemicals in these flavors may affect the… Read More »

Novartis’ new cell therapy facility could ease manufacturing squeeze for CAR-T med Kymriah

Novartis’ big push into cell and gene therapy hasn’t been the smoothest of rides, with a data manipulation scandal hamstringing Zolgensma and manufacturing concerns hurting CAR-T cancer therapy Kymriah. Could a new European facility help turn around the latter’s production bottleneck?  Novartis last week opened its newest cell and gene therapy facility in Stein, Switzerland,… Read More »

FDA Approves Reblozyl (luspatercept-aamt) for the Treatment of Anemia in Adults With Beta Thalassemia Who Require Regular Red Blood Cell Transfusions

FDA Approves Reblozyl (luspatercept-aamt) for the Treatment of Anemia in Adults With Beta Thalassemia Who Require Regular Red Blood Cell Transfusions Print this page SUMMIT, N.J. & CAMBRIDGE, Mass.–(BUSINESS WIRE)– Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced the U.S. Food and Drug Administration (FDA) has approved Reblozyl (luspatercept-aamt) for the… Read More »

Expert: Turkey beats West in stem cell treatment

Turkey provides cutting-edge medical services, including stem cell transplants, to millions – including the refugees it hosts – said a Turkish professor of hematology. Fevzi Altuntaş told Anadolu Agency (AA) that Turkey emulated developed countries in the West in its drive to offer patients high-end medical services. Altuntaş, founder of Turkish cord blood and bone… Read More »